Prof. Dr. Ahmet OMMA

1. Serum calprotectin as a biomarker for large vessel vasculitis: a multicenter cross-sectional study

Çöpür S., Avcu A., Dik Kutlu N., Yuruk Kitay F. D., Akyüz Dağlı P., Kutu M. E., et al.

International Immunopharmacology , cilt.187, 2026 (SCI-Expanded, Scopus)

2. Screening of osteoporosis in patients with ANCA-associated vasculitis (AAV) is quite low: results from a country-wide study

DEMİRCİ YILDIRIM T., Erpek E., Ulusoy B. Ö., Uzun G. S., YAZICI A., Kardaş R. C., et al.

Internal and Emergency Medicine , cilt.21, sa.5, ss.1647-1654, 2026 (SCI-Expanded, Scopus)

3. Real-world experience of rituximab therapy in ANCA-associated vasculitis according to renal involvement ANCA ilişkili vaskülitte renal tutuluma göre rituksimab tedavisi: Gerçek yaşam deneyimi

Deniz R., Dağlı P. A., Işık A., Ocak T., Uludoğan B. C. E., Uğur K., et al.

Journal of Turkish Society For Rheumatology , cilt.18, sa.2, ss.173-180, 2026 (Scopus, TRDizin)

4. Can baseline features predict progression to defined connective tissue disease? Insights from a minimum 5-year follow-up study of 504 patients with undifferentiated connective tissue disease: A retrospective study

Apaydin H., Sağirkaya Ş. Ç., Polat B., Armağan B., OMMA A., ERTEN Ş., et al.

Modern Rheumatology , cilt.36, sa.4, ss.619-626, 2026 (SCI-Expanded, Scopus)

5. Plasma Lipidomic Remodeling in Behçet’s Disease Reveals Alterations Associated with Vascular Involvement

KOÇAK E., YÜCEL Ç., Kablan S. E., SERTOĞLU E., ÖZGÜRTAŞ T., NEMUTLU E., et al.

Metabolites , cilt.16, sa.6, 2026 (SCI-Expanded, Scopus)

6. Non-pulmonary arterial involvement in Behçet’s disease: a multicenter retrospective case series

Karakök Ö., Kerim D., Çoşkun Sağirkaya Ş., Akkuzu G., ULUDOĞAN B. C., KİMYON G., et al.

Turkish Journal of Medical Sciences , cilt.56, sa.3, ss.730-739, 2026 (SCI-Expanded, Scopus, TRDizin)

7. Genetic susceptibility and validation of angiographic patterns in Takayasu arteritis

Casares-Marfil D., Gribbons K. B., Saruhan-Direskeneli G., Kaymaz-Tahra S., Quinn K. A., ALİBAZ F., et al.

Journal of Autoimmunity , cilt.157, 2025 (SCI-Expanded, Scopus)

8. Venous Thromboembolism May Be Increased in the Early Phases of ANCA-Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR-VaS Experience

Kocaayan H., Ediboglu E. D., DEMİRCİ YILDIRIM T., Ulusoy B. O., Ogut T. S., Firlatan B., et al.

International Journal of Rheumatic Diseases , cilt.28, sa.12, 2025 (SCI-Expanded, Scopus)

9. Turkish Society for Rheumatology guideline for the management of ANCA-associated vasculitides Türkiye Romatoloji Derneği ANCA ilişkili (asosiye) vaskülitler hastalık yönetimi kılavuzu

KARADAĞ Ö., Sarıyıldız E., Dağlı P. A., Gerçik Ö., Kardaş R. C., Şahin D., et al.

Journal of Turkish Society For Rheumatology , cilt.17, sa.3, ss.131-144, 2025 (Scopus, TRDizin)

10. Prognostic significance and rationality of regular non-invasive imaging follow-up in Takayasu arteritis: A large multicenter cohort study

Yıldırım F., Tastekin F., Bakkal S., Kutu M. E., Ocak T., San S., et al.

Seminars in Arthritis and Rheumatism , cilt.74, 2025 (SCI-Expanded, Scopus)

11. Medication adherence and real-world factors of first line induction treatment selection in ANCA-associated vasculitis

Dağlı P. A., Erdoğan E. K., Konak H. E., Ulusoy B. Ö., Güven S. C., Armağan B., et al.

Sarcoidosis Vasculitis and Diffuse Lung Diseases , cilt.42, sa.3, 2025 (SCI-Expanded, Scopus)

12. SEASONAL VARIATION IN INCIDENCE AND RELAPSE OF GRANULOMATOSIS WITH POLYANGIITIS: A RETROSPECTIVE COHORT STUDY FROM CENTRAL ANATOLIA

Soytürk G., Konak H. E., Dağlı P. A., Ulucaköy R. K., Atalar E., Erdoğan E. K., et al.

Sarcoidosis Vasculitis and Diffuse Lung Diseases , cilt.42, sa.2, 2025 (SCI-Expanded, Scopus)

13. Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients

Kayacan Erdoğan E., Armağan B., Koçak Ulucaköy R., Orhan K., Can Güven S., Özdemir Ulusoy B., et al.

Wiener Klinische Wochenschrift , cilt.137, sa.1, ss.49-55, 2025 (SCI-Expanded, Scopus)

14. Long-term outcomes of aortic valve insufficiency in patients with Takayasu arteritis

Yağmur F. H., Kutu M. E., Tastekin F., Avcu A., Şan S., Ocak T., et al.

Frontiers in Immunology , cilt.16, 2025 (SCI-Expanded, Scopus)

15. Rheumatic diseases presenting with young ischemic stroke: Revelations from tertiary center experience Genç iskemi inme ile seyreden romatolojik hastaliklar: Üçüncü basamak merkez deneyimi

Konak H. E., Guven S. C., Atalar E., Akyuz Dagli P., Kocak Ulucakoy R., Kayacan Erdogan E., et al.

Northern Clinics of Istanbul , cilt.12, sa.1, ss.103-110, 2025 (ESCI, Scopus, TRDizin)

16. Is the visceral adiposity index associated with the presence of cardiovascular risk scores and comorbidity in psoriatic disease? Psöriyatik hastalıkta viseral yağlanma indeksi kardiyovasküler risk skorları ve komorbidite ile ilişkili mi?

OMMA A., Erden F., Çolak S. Y., CAN SANDIKÇI S., Omma T., Kasım İ., et al.

Journal of Turkish Society For Rheumatology , cilt.16, sa.3, ss.90-96, 2024 (Scopus, TRDizin)

17. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies

Uzun G. S., GÖKÖZ Ö., ÖĞÜT B., HEPER A., Güreşçi S., Kardaş R. C., et al.

Rheumatology International , cilt.44, sa.11, ss.2547-2554, 2024 (SCI-Expanded, Scopus)

18. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

BİLGİN E., DEMİRCİ YILDIRIM T., Özdemir Ulusoy B., Öğüt T. S., KARABACAK M., Sadioğlu Çağdaş Ö., et al.

Internal and Emergency Medicine , cilt.19, sa.4, ss.1025-1034, 2024 (SCI-Expanded, Scopus)

19. The burden of face affected questionnaire in patients with systemic sclerosis: Translation, cross-cultural adaptation and psychometric properties in the Turkish version

Sari F., Apaydin Z. B., Apaydin H. A., Kayaalp M., ERDEN A., Güven S. C., et al.

Egyptian Rheumatologist , cilt.46, sa.2, ss.56-61, 2024 (ESCI, Scopus)

20. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry

ALİBAZ F., Kelesoglu B., Balci M. A., Yardimci G. K., Armağan B., KILIÇ L., et al.

Clinical and Experimental Rheumatology , cilt.42, sa.4, ss.816-821, 2024 (SCI-Expanded, Scopus)

21. Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity

Akyüz Dağlı P., ERDEN A., Babaoğlu H., Karakaş Ö., Özdemir Ulusoy B., Konak H. E., et al.

Irish Journal of Medical Science , cilt.193, sa.2, ss.1099-1107, 2024 (SCI-Expanded, Scopus)

22. Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis

Sari F., Bazancir Apaydin Z., Apaydin H., Kayaalp M., ERDEN A., Güven S. C., et al.

Archives of Rheumatology , cilt.39, sa.1, ss.52-59, 2024 (SCI-Expanded, Scopus)

23. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients

Avanoglu Güler A., Özçimen B., Aydoğdu M. S., Sari A., Numune A., Tüzün Ersan N., et al.

Turkish Journal of Medical Sciences , cilt.54, sa.1, ss.76-85, 2024 (SCI-Expanded, Scopus, TRDizin)

24. Baseline capillaroscopy provides no evidence of microvascular changes to predict long-COVID syndrome

Ulusoy B. O., Babaoglu H., Armagan B., ALTUNSOY A., AKINCI E., KÜÇÜKŞAHİN O., et al.

Bratislava Medical Journal , cilt.125, sa.8, ss.497-502, 2024 (SCI-Expanded, Scopus)

25. INTERSTITIAL LUNG DISEASE IN PRIMARY SJÖGREN’S SYNDROME: RISK FACTORS FOR OCCURRENCE AND RADIOGRAPHIC PROGRESSION

Konak H. E., Atalar E., Hezer H., Ulucaköy R. K., Erdoğan E. K., Babaoğlu H., et al.

Sarcoidosis Vasculitis and Diffuse Lung Diseases , cilt.41, sa.3, 2024 (SCI-Expanded, Scopus)

26. Comorbidity Profiles in Inflammatory Rheumatic Diseases: An Analytical Perspective

Koçak Ulucaköy R., Babaoǧlu H., Kayacan Erdoǧan E., Orhan K., Atalar E., Güven S. C., et al.

International Journal of Clinical Practice , cilt.2024, 2024 (SCI-Expanded, Scopus)

27. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: Real life experience from the TReasure Registry

KARADAĞ Ö., Farisogullari B., YAĞIZ B., ERDEN A., Ademoglu Z., KİMYON G., et al.

Clinical and Experimental Rheumatology , cilt.42, sa.1, ss.130-137, 2024 (SCI-Expanded, Scopus)

28. Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis

Kayaalp M., ERDEN A., Apaydin H., Güven S. C., Armaǧan B., Kayaalp M. C., et al.

Lab Medicine , cilt.54, sa.6, ss.646-651, 2023 (SCI-Expanded, Scopus)

29. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

ATEŞ İ., BATIREL A., AYDIN M., YILMAZ KARADAĞ F., ERDEN A., KÜÇÜKŞAHİN O., et al.

Vaccines , cilt.11, sa.7, 2023 (SCI-Expanded, Scopus)

30. COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab

Armağan B., Konak H. E., Özdemir B., Apaydın H., Atalar E., Akyüz Dağlı P., et al.

International Journal of Rheumatic Diseases , cilt.26, sa.5, ss.930-937, 2023 (SCI-Expanded, Scopus)

31. Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study

Karakaş Ö., ERDEN A., Armağan B., Güven S. C., Atalar E., Polat B., et al.

International Journal of Rheumatic Diseases , cilt.26, sa.2, ss.292-297, 2023 (SCI-Expanded, Scopus)

32. Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)

ERDEN A., Ayan G., KILIÇ L., Solmaz D., BAKIRCI S., KİMYON G., et al.

Clinical Rheumatology , cilt.42, sa.2, ss.385-390, 2023 (SCI-Expanded, Scopus)

33. Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center

Armağan B., Atalar E., Güven S. C., Özdemir B., Konak H. E., Akyüz Dağlı P., et al.

Immunopharmacology and Immunotoxicology , cilt.45, sa.4, ss.395-401, 2023 (SCI-Expanded, Scopus)

34. A single-center rheumatology experience of sarcoidosis: Observations from 70 patients

Konak H. E., Güven S. C., Atalar E., Dağlı P. A., Ulucaköy R. K., Erdoğan E. K., et al.

Sarcoidosis Vasculitis and Diffuse Lung Diseases , cilt.40, sa.3, 2023 (SCI-Expanded, Scopus)

35. Derivation and validation of adult Still Activity Score (SAS)

KALYONCU U., KAŞİFOĞLU T., OMMA A., BES C., Cinar M., EMMUNGİL H., et al.

Joint Bone Spine , cilt.90, sa.1, 2023 (SCI-Expanded, Scopus)

36. Restless leg syndrome and sleep quality in granulomatosis with polyangiitis Granülomatöz polianjit hastalarında uyku kalitesi ve huzursuz bacak sendromu

Güven S. C., Dağlı P. A., Karacaoğlu S., Armağan B., ERDEN A., KÜÇÜKŞAHİN O., et al.

Journal of Turkish Society For Rheumatology , cilt.14, sa.3, ss.124-130, 2022 (Scopus, TRDizin)

37. Effects of anti-SARS-CoV-2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort

Apaydin H., ERDEN A., Güven S. C., Armağan B., Konak H. E., Polat B., et al.

International Journal of Rheumatic Diseases , cilt.25, sa.9, ss.1068-1077, 2022 (SCI-Expanded, Scopus)

38. Intravenous treatment adherence of patients with chronic inflammatory rheumatic diseases during the COVID-19 pandemic: experience of a single center

Konak H. E., Armağan B., Güven S. C., Atalar E., Karakaş Ö., Esmer S., et al.

Romanian journal of internal medicine = Revue roumaine de medecine interne , cilt.60, sa.3, ss.173-181, 2022 (ESCI, Scopus)

39. A single-center COVID-19 vaccine experience with CoronaVac and BNT162b2 in familial Mediterranean fever patients

Güven S. C., Karakaş Ö., Atalar E., Konak H. E., Akyüz Dağlı P., Kayacan Erdoğan E., et al.

International Journal of Rheumatic Diseases , cilt.25, sa.7, ss.787-794, 2022 (SCI-Expanded, Scopus)

40. Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19

Güven S. C., Apaydln H., Özdemir B., Armaǧan B., ATEŞ İ., ERDEN A., et al.

Future Virology , cilt.17, sa.4, ss.239-245, 2022 (SCI-Expanded, Scopus)

41. Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: A case series with literature review

Eksin M. A., ERDEN A., Güven S. C., Armagan B., Ozdemir B., Karakas O., et al.

Immunotherapy , cilt.14, sa.6, ss.401-408, 2022 (SCI-Expanded, Scopus)

42. Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGFgene polymorphisms in patients with Behçet’s uveitis

SERTOĞLU E., YÜCEL Ç., OMMA A., Hayran Y., Colak S., CAN SANDIKÇI S., et al.

Advances in Clinical and Experimental Medicine , cilt.31, sa.3, ss.231-240, 2022 (SCI-Expanded, Scopus)

43. Evaluation of Coronavirus Disease-2019 Patients with Nailfold Capillaroscopy Koronavirüs Hastalığı-2019 Hastalarının Tırnak Dibi Kapilleroskopisi ile Değerlendirilmesi

Armağan B., Özdemir B., Altunsoy Aypak A., AKINCI E., Karakaş Ö., Güven S. C., et al.

Namik Kemal Medical Journal , cilt.10, sa.1, ss.80-86, 2022 (Scopus, TRDizin)

44. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

MERT A., VAHABOĞLU H., Arslan F., BATIREL A., Saraçoğlu K. T., BAŞTUĞ A., et al.

Rheumatology International , cilt.42, sa.3, ss.457-467, 2022 (SCI-Expanded, Scopus)

45. COVID-19 in patients with Behçet's disease: Outcomes and rate of Behçet's exacerbations in a retrospective cohort

Polat B., ERDEN A., Güven S. C., Armaǧan B., Karakaş Ö., Özdemir B., et al.

Modern Rheumatology , cilt.32, sa.2, ss.455-459, 2022 (SCI-Expanded, Scopus)

46. Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study

KÜÇÜKŞAHİN O., ERDEN A., Karakaş Ö., Güven S. C., Armağan B., Şahiner E. S., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.5, ss.1486-1494, 2022 (SCI-Expanded, Scopus, TRDizin)

47. Budd–Chiari syndrome in Behçet’s disease: a retrospective multicenter study

Akyol L., Toz B., Bayındır Ö., Zengin O., ÜSKÜDAR CANSU D., Yiğit M., et al.

Clinical Rheumatology , cilt.41, sa.1, ss.177-186, 2022 (SCI-Expanded, Scopus)

48. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

OMMA A., BATIREL A., AYDIN M., YILMAZ KARADAĞ F., ERDEN A., KÜÇÜKŞAHİN O., et al.

Human Vaccines and Immunotherapeutics , cilt.18, sa.6, 2022 (SCI-Expanded, Scopus)

49. Evaluation of oxidative stress in gout disease; thiol-disulfide homeostasis and ischemia-modified albumin levels

Balik A. R., OMMA A., CAN SANDIKÇI S., YÜCEL Ç., Kizilgun M., Balik Z. B., et al.

International Journal of Medical Biochemistry , cilt.5, sa.2, ss.109-115, 2022 (Scopus, TRDizin)

50. COVID-19 outcomes in patients with antiphospholipid syndrome: a retrospective cohort study

ERDEN A., Karakas O., Armagan B., Guven S., Ozdemir B., Atalar E., et al.

Bratislava Medical Journal , cilt.123, sa.2, ss.120-124, 2022 (SCI-Expanded, Scopus)

51. An evaluation of the results of convalescent plasma therapy applied to pregnant women diagnosed as COVID-19-positive in a pandemic center: A prospective cohort study

Erol S. A., TANAÇAN A., Apaydin H., Göncü Ayhan Ş., Oluklu D., Uyan Hendem D., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.3, ss.554-564, 2022 (SCI-Expanded, Scopus, TRDizin)

52. Evaluation of the relationship of lymphangiogenesis markers with disease pathogenesis in patients with Behçet’s uveitis

ÖZGÜRTAŞ T., YÜCEL Ç., SERTOĞLU E., Hayran Y., Çolak S., TEKGÖZ E., et al.

Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , cilt.77, sa.2, ss.387-395, 2022 (SCI-Expanded, Scopus)

53. A single center experience of intravenous immunoglobulin treatment in Covid-19

OMMA A., ERDEN A., Armağan B., Güven S. C., Karakaş Ö., Şahiner E. S., et al.

International Immunopharmacology , cilt.98, 2021 (SCI-Expanded, Scopus)

54. Association of disease characteristics with the temporal sequence of skin and musculoskeletal disease onset in psoriatic arthritis

Tascilar K., Bayindir O., Dogru A., Tinazzi I., Kimyon G., ÖZİŞLER C., et al.

British Journal of Dermatology , cilt.184, sa.6, ss.1202-1203, 2021 (SCI-Expanded, Scopus)

55. Serum VEGF-A and VEGFR-1 levels in patients with adult immunoglobulin A vasculitis

Yücel Ç., SERTOĞLU E., Fırat Oğuz E., Hayran Y., OMMA A., ÖZGÜRTAŞ T.

International Journal of Rheumatic Diseases , cilt.24, sa.6, ss.789-794, 2021 (SCI-Expanded, Scopus)

56. Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: Cross-sectional data from the psoriatic arthritis-international database

BİLGİN E., Aydin S., Tinazzi I., Bayindir Ö., KİMYON G., ÖZİŞLER C., et al.

Clinical and Experimental Rheumatology , cilt.39, sa.3, ss.532-536, 2021 (SCI-Expanded, Scopus)

57. Comparison of relapse rates in Behçet’s disease with venous involvement on different doses of azathioprine therapy, a retrospective observational study

Girgin S., Yurumez S., OMMA A., ÇELİK S., Cemal Icacan O., BES C., et al.

International Journal of Rheumatic Diseases , cilt.24, sa.4, ss.562-566, 2021 (SCI-Expanded, Scopus)

58. PsART-ID inception cohort: Clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis

Ayan G., Aydin S. Z., KİMYON G., ÖZİŞLER C., Tinazzi I., DOĞRU A., et al.

Rheumatology (United Kingdom) , cilt.60, sa.4, ss.1755-1762, 2021 (SCI-Expanded, Scopus)

59. Can Anakinra and corticosteroid treatment be an effective option in pregnant women with severe Covid-19?

Karakaş Ö., ERDEN A., Ünlü S., Erol S. A., Goncu Ayhan Ş., Özdemir B., et al.

Women and Health , cilt.61, sa.9, ss.872-879, 2021 (SSCI, Scopus)

60. The effects of educational status and comorbidity on routine assessment of patient index data 3 and its correlation with disease activity score 28 and clinical disease activity index

Sahin K., ÖZİŞLER C., Yesil N. K., Dortbas F., OMMA A., Aslar Z. O., et al.

Indian Journal of Rheumatology , cilt.15, sa.4, ss.292-297, 2020 (ESCI, Scopus)

61. Favorable retention rates and safety of conventional anti-rheumatic drugs in older patients with rheumatoid arthritis

Alpay-Kanıtez N., PEHLİVAN Ö., OMMA A., CAN SANDIKÇI S., Girgin S., Içaçan O. C., et al.

Medicine (United States) , cilt.99, sa.16, 2020 (SCI-Expanded, Scopus)

62. Damage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort

Gazel U., Colak S., Sari A., ÜSKÜDAR CANSU D., YAZICI A., ÇEFLE A., et al.

Clinical and experimental rheumatology , cilt.38, sa.2, ss.155-160, 2020 (SCI-Expanded, Scopus)

63. Efficacy of TNFα inhibitors for refractory vascular Behçet's disease: A multicenter observational study of 27 patients and a review of the literature

Aksoy A., YAZICI A., OMMA A., ÇEFLE A., Onen F., Tasdemir U., et al.

International Journal of Rheumatic Diseases , cilt.23, sa.2, ss.256-261, 2020 (SCI-Expanded, Scopus)

64. Evaluation of atherogenic laboratory markers in Behçet's disease patients with vascular involvement

YÜCEL Ç., OMMA A., SERTOĞLU E., Sezer S., TURHAN T., ÖZGÜRTAŞ T.

Archives of Medical Science , cilt.16, sa.2, ss.531-537, 2020 (SCI-Expanded, Scopus)

65. Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease

Solmaz D., BAKIRCI S., KİMYON G., Gunal E. K., DOĞRU A., Bayindir O., et al.

Arthritis Care and Research , cilt.72, sa.1, ss.63-68, 2020 (SCI-Expanded, Scopus)

66. Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch-Schönlein purpura)

OMMA A., Colak S., CAN SANDIKÇI S., Yucel C., ERDEN A., SERTOĞLU E., et al.

International Journal of Rheumatic Diseases , cilt.22, sa.10, ss.1920-1925, 2019 (SCI-Expanded, Scopus)

67. What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?

BAKIRCI S., Solmaz D., Al Osaimi N., DALKILIÇ H. E., CAN M., ERDEN A., et al.

Clinical and experimental rheumatology , cilt.37, sa.5, ss.808-812, 2019 (SCI-Expanded, Scopus)

68. Comparison of optical coherence tomography angiography results of adult patients with Familial Mediterranean fever and healthy individuals

KARACA E. E., Ozek D., OMMA A., EVREN KEMER Ö.

Therapeutic Advances in Ophthalmology , cilt.11, 2019 (Scopus)

69. Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life

Aydin S. Z., KÜÇÜKŞAHİN O., KILIÇ L., DOĞRU A., Bayindir O., ÖZİŞLER C., et al.

Clinical Rheumatology , cilt.37, sa.12, ss.3443-3448, 2018 (SCI-Expanded, Scopus)

70. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease

SERTOĞLU E., OMMA A., YÜCEL Ç., Colak S., CAN SANDIKÇI S., ÖZGÜRTAŞ T.

Scandinavian Journal of Clinical and Laboratory Investigation , cilt.78, sa.6, ss.443-449, 2018 (SCI-Expanded, Scopus)

71. Short report: correlates of functional disability with disease activity in elderly patients with rheumatoid arthritis

OMMA A., Çelik S., BES C., PEHLİVAN Ö., CAN SANDIKÇI S., YILMAZ ÖNER S., et al.

Psychology, Health and Medicine , cilt.23, sa.6, ss.668-673, 2018 (SCI-Expanded, SSCI, Scopus)

72. Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients

Akar S., Cetin P., KALYONCU U., KARADAĞ Ö., SARI İ., Cınar M., et al.

Arthritis Care and Research , cilt.70, sa.7, ss.1090-1094, 2018 (SCI-Expanded, Scopus)

73. The Psoriatic Arthritis Registry of Turkey: Results of a multicentre registry on 1081 patients

KALYONCU U., Bayindir Ö., Öksüz M. F., DOĞRU A., Kimyon G., Tarhan E. F., et al.

Rheumatology (United Kingdom) , cilt.56, sa.2, ss.279-286, 2017 (SCI-Expanded, Scopus)

74. Behçet disease with vascular involvement: Effects of different therapeutic regimens on the incidence of new relapses

ALİBAZ F., KARADENİZ A., Yilmaz S., Balkarli A., Kimyon G., YAZICI A., et al.

Medicine (United States) , cilt.94, sa.6, 2015 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim